MedPath

A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine

Phase 3
Completed
Conditions
Migraine
Registration Number
NCT00300924
Lead Sponsor
Diamond Headache Clinic
Brief Summary

The purpose of this study is to test an experimental drug combination of two medications currently approved by the Food and Drug Administration (FDA) for migraine headache or other pain. These are called rizatriptan given with acetaminophen.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Subject is at least 18 years of age
  • Subject has at least a 6 month history of migraine, with or without aura
  • Subject can distinguish between migraine attacks and other types of headaches
  • Subject of childbearing potential agrees to use adequate contraception
Exclusion Criteria
  • Subject typically has fewer than 1 or greater than 6 migraine attacks per month
  • Subject typically has greater than 10 headache days per month
  • Subject has evidence of ischemic heart disease
  • Subject has uncontrolled high blood pressure
  • Subject has a history, within 1 year, or current evidence of drug or alcohol abuse

*This list is not all inclusive*

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of rizatriptan co-administered with acetaminophen to placebo, acetaminophen and rizatriptan for the acute treatment of migraine, as measured by the percentage of patients with pain relief at 2 hours.
Secondary Outcome Measures
NameTimeMethod
24 hour sustained pain relief
Pain relief at 30, 45,60,90 minutes and 4 hours post dose
Pain freedom at 30,45,60,90 minutes and 2 and 4 hours post dose
24 sustained pain freedom
Associated symptoms of phonophobia, photophobia, nausea and vomiting
Functional disability
Use of rescue medication
Self-reported adverse experiences

Trial Locations

Locations (7)

Diamond Headache Clinic

🇺🇸

Chicago, Illinois, United States

Elkind Headache Center

🇺🇸

Mount Vernon, New York, United States

Clinvest

🇺🇸

Springfield, Missouri, United States

ClinExcel

🇺🇸

West Chester, Ohio, United States

Westside Family Medical Center

🇺🇸

Kalamazoo, Michigan, United States

SanFrancisco Headache Clinic

🇺🇸

San Francisco, California, United States

Mercy Health Research

🇺🇸

St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath